摘要
炎症性肠病的患者的最佳护理是:坚持基于诊断的标准的护理,告知病人治疗的潜在风险,获取推荐的基线研究和监测病人的疗效和副作用。在临床研究和实践中,经济利益冲突必须公开和设法确保病人有足够的信息来做出决定是否参与一项研究,并确保他们的安全。护理人员的医学教育培训有义务和责任来监督IBD患者的护理来确保安全和最优的护理。本文解决炎症性肠病患者护理中出现的法医学难题。临床医师必须使用适当的诊断和治疗选择为炎症性肠病(IBD) 患者提供最佳的护理,并遵循标准的护理和伦理原则。如果不坚持标准医疗护理、临床研究和教育将导致道德和法医学的问题出现。在2011年《新英格兰医学杂志》的一份报告上,在美国26项医疗事故最常见的起诉中肠胃科排名第六,平均支付原告略少于200,000美元[1]。值得注意的是其他两个涉及创伤性手术,在名单上的排名低于胃肠病学。例如,心脏病和麻醉学分别排名11位和17位。在这篇综述中,在IBD需要遵守的实践标准的九个陷阱进行了综述。
关键词: 克罗恩氏病,炎症性肠病,医学事故, 法医,溃疡性结肠炎。
Current Drug Targets
Title:Nine Medico-Legal Pitfalls in Inflammatory Bowel Disease in the United States
Volume: 15 Issue: 11
Author(s): William J. Tremaine
Affiliation:
关键词: 克罗恩氏病,炎症性肠病,医学事故, 法医,溃疡性结肠炎。
摘要: The optimal care of patients with inflammatory bowel disease depends on adherence to standards of care regarding diagnosis, informing the patient of potential risks of treatment, obtaining recommended baseline studies, and monitoring the patient for efficacy and adverse effects. In clinical research as well as practice, financial conflicts of interest must be disclosed and managed to insure that patients have sufficient information to make a decision regarding participation in a study and to insure their safety. Medical education of care-givers in training carries the obligation and liability to oversee the care of the IBD patient and insure that safe and optimal care. This review addresses medicolegal issues that can arise in the care of the patient with IBD. Clinicians who provide optimal care for patients with inflammatory bowel diseases (IBD) must employ appropriate diagnostic and therapeutic options and also adhere to standards of care and ethical principles. Ethical and medicolegal issues can arise from the failure to adhere to the standards of medical care, clinical research and education. In a report in the New England Journal of Medicine in 2011, gastroenterologists in the U.S. ranked 6th out 26 subspecialities as the most commonly sued for malpractice, with the mean payment to the plaintiff of just under $200,000 [1]. It is noteworthy that two other specialties that involve invasive procedures ranked lower on the list than Gastroenterology. For example, Cardiology and Anesthesiology ranked 11th and 17th, respectively. In this review, nine of the pitfalls to adherence to the standards of practice for IBD are reviewed.
Export Options
About this article
Cite this article as:
Tremaine J. William, Nine Medico-Legal Pitfalls in Inflammatory Bowel Disease in the United States, Current Drug Targets 2014; 15 (11) . https://dx.doi.org/10.2174/1389450115666140828124238
DOI https://dx.doi.org/10.2174/1389450115666140828124238 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Whos Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori
Current Drug Therapy Exploring Interaction of TNF and Orthopoxviral CrmB Protein by Surface Plasmon Resonance and Free Energy Calculation
Protein & Peptide Letters Rapid and Convenient CuCl2 Catalysed Microwave-Assisted Synthesis of Novel Spiro [indoline-3,4'-quinoline] Derivatives
Current Microwave Chemistry Pleural Involvement in Systemic Disorders
Current Drug Targets - Inflammation & Allergy Therapeutic Outlook of Pyrazole Analogs: A Mini Review
Mini-Reviews in Medicinal Chemistry Nanomedicine Against Malaria
Current Medicinal Chemistry Itraconazole Induced Congestive Heart Failure, A Case Study
Current Drug Safety Therapeutic Use of Antioxidants in Sepsis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Synthesis of 99mTc-Rifabutin: A Potential Tuberculosis Radiodiagnostic Agent
Infectious Disorders - Drug Targets Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period
Current Clinical Pharmacology Sulphur-Containing Heterocycles as Antimycobacterial Agents: Recent Advances in Thiophene and Thiadiazole Derivatives
Current Topics in Medicinal Chemistry Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews Advancements in Adjuvanticity of Bioactive Inorganic and Organic Compounds
Endocrine, Metabolic & Immune Disorders - Drug Targets A Collaborative Edge-Cloud Internet of Things Based Framework for Securing the Indian Healthcare System
International Journal of Sensors, Wireless Communications and Control Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Antibiotics with Antiviral and Anti-Inflammatory Potential Against Covid-19: A Review
Current Reviews in Clinical and Experimental Pharmacology Development and Characterization of Novel Medicated Nanofibers Against Periodontitis
Current Drug Delivery Gene Therapy by Liver Transplantation and Single Stranded Oligonucleotides (SSOs) in Familial Amyloidotic Polyneuropathy (FAP)
Current Pharmacogenomics Adipokines, Metabolism and the Immune Response in the Regulation of Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Meet Our Editorial Board Member
Drug Delivery Letters